Moreover, these sample-specific active promoters are functionally important, as they drive the expression of several cancer consensus genes, including MYC. This observation is consistent with recent reports of heterogeneous enhancer activities of cell line-defined super-enhancers in primary gastric cancers [71], emphasizing the critical importance of deriving sample-specific epigenomic signatures. The gene discussed is MYC; the disease is cancer.